Blockchain Registration Transaction Record

Aditxt Announces 1-for-113 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt implements 1-for-113 reverse stock split effective Nov 3, 2025 to regain Nasdaq compliance. The health innovation platform focuses on autoimmunity, cancer detection & women's health.

This development matters because reverse stock splits often signal a company's determination to maintain its exchange listing, which can affect investor confidence and liquidity. For Aditxt shareholders, the consolidation reduces the number of shares but maintains proportional ownership, while the move to meet Nasdaq requirements suggests management is taking steps to preserve the stock's market presence. In the broader context, maintaining a Nasdaq listing provides continued visibility and access to capital markets, which is crucial for funding Aditxt's health innovation programs in autoimmunity, cancer detection, infectious diseases, and women's health. The company's unique social innovation model, which collaborates with research institutions and industry partners, represents an emerging approach to healthcare development that could yield significant medical advancements if properly funded and executed.